Angelo P Tanna

  • 289 Citations
If you made any changes in Pure, your changes will be visible here soon.

Personal profile

Research Interests

Clinical interests: Glaucoma and cataract. Normal-Tension Glaucoma, Pigmentary Glaucoma, Pseudoexfoliation Glaucoma. Early Diagnosis of Glaucoma. Research interets: Selective Perimetry for the Early Diagnosis of Glaucoma, Optic Nerve and Retinal Spectral Domain Optical Coherence Tomography Imaging, Tonometry, Efficacy and Safety of Glaucoma Medications, Epidemiology of Glaucoma.

Certifications and Licenses


Training Experience

1995Internship, Graduate Hospital, in affiliation with the Hospital of the University of Pennsylvania
1998Residency, Johns Hopkins Hospital
1999Fellowship, Johns Hopkins Hospital

Education/Academic qualification

MD, Columbia College of Physicians and Surgeons

… → 1994


  • Electrophysiology
  • Epidemiology
  • Ophthalmology

Fingerprint Fingerprint is based on mining the text of the experts' scientific documents to create an index of weighted terms, which defines the key subjects of each individual researcher.

  • 4 Similar Profiles
Glaucoma Medicine & Life Sciences
Intraocular Pressure Medicine & Life Sciences
Visual Fields Medicine & Life Sciences
Visual Field Tests Medicine & Life Sciences
Ocular Hypertension Medicine & Life Sciences
Low Tension Glaucoma Medicine & Life Sciences
Retinoschisis Medicine & Life Sciences
Optical Coherence Tomography Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Grants 2004 2019

Research Output 1994 2019

PANRETINAL PHOTOCOAGULATION VERSUS RANIBIZUMAB FOR PROLIFERATIVE DIABETIC RETINOPATHY: Comparison of Peripapillary Retinal Nerve Fiber Layer Thickness in a Randomized Clinical Trial

Diabetic Retinopathy Clinical Research Network, Jan 1 2019, In : Retina (Philadelphia, Pa.). 39, 1, p. 69-78 10 p.

Research output: Contribution to journalArticle

Light Coagulation
Diabetic Retinopathy
Nerve Fibers
Randomized Controlled Trials
Visual Fields

Geographic and Provider Variations in Ocular Hypotensive Medication Claims among Medicare Part D Enrollees

Janetos, T. M., French, D. D., Beaumont, J. L. & Tanna, A. P., Jan 1 2018, (Accepted/In press) In : Journal of Glaucoma.

Research output: Contribution to journalArticle

Medicare Part D
Observational Studies
2 Citations

Rho Kinase Inhibitors as a Novel Treatment for Glaucoma and Ocular Hypertension

Tanna, A. P. & Johnson, M., Nov 1 2018, In : Ophthalmology. 125, 11, p. 1741-1756 16 p.

Research output: Contribution to journalReview article

rho-Associated Kinases
Ocular Hypertension
Intraocular Pressure

The effect of cutaneous prostaglandin application on nail growth, nail brittleness, and intraocular pressure

Palmer, D. J., Scheman, A., Tanna, A. P. & Bueno, A., Apr 1 2018, In : Journal of Cosmetic Dermatology. 17, 2, p. 263-267 5 p.

Research output: Contribution to journalArticle

Intraocular Pressure
2 Citations

Growing evidence of the importance of the macula in glaucoma

Tanna, A. P., Jul 1 2017, In : JAMA Ophthalmology. 135, 7, p. 747-748 2 p.

Research output: Contribution to journalComment/debate